(Q36287536)

13 August 2017

1 reference

title

Cytokine signal regulation and autoimmune disorders (English)

1 reference

13 August 2017

Norihiro Nishimoto

1

1 reference

PubMed ID

16227151

13 August 2017

language of work or name

1 reference

1 August 2005

1 reference

13 August 2017

1 reference

13 August 2017

38

1 reference

13 August 2017

5

1 reference

13 August 2017

359-367

1 reference

Cytokine signal transduction

13 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F08916930500124106

New drugs for rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930500124106

Cloning and expression of the human interleukin-6 (BSF-2/IFN beta 2) receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930500124106

Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930500124106

Molecular cloning and expression of an IL-6 signal transducer, gp130

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930500124106

Rheumatoid arthritis. Pathophysiology and implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930500124106

Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930500124106

Human interleukin 6 is a direct promoter of maturation of megakaryocytes in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930500124106

Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930500124106

Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930500124106

Enhanced production of interleukin-6 in mice with type II collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930500124106

Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930500124106

Interleukin 6 plays a key role in the development of antigen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930500124106

Induction of inflammatory arthropathy resembling rheumatoid arthritis in mice transgenic for HTLV-I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930500124106

Suppression of autoimmune arthritis in interleukin-1-deficient mice in which T cell activation is impaired due to low levels of CD40 ligand and OX40 expression on T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930500124106

Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930500124106

IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930500124106

A point mutation of Tyr-759 in interleukin 6 family cytokine receptor subunit gp130 causes autoimmune arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930500124106

Suppressed severity of collagen-induced arthritis by in vivo transfection of nuclear factor kappaB decoy oligodeoxynucleotides as a gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930500124106

Transcription factor decoy for NFkappaB inhibits cytokine and adhesion molecule expressions in synovial cells derived from rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930500124106

Induction of the cytokine signal regulator SOCS3/CIS3 as a therapeutic strategy for treating inflammatory arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930500124106

Treatment of rheumatoid synovitis with anti-reshaping human interleukin-6 receptor monoclonal antibody: use of rheumatoid arthritis tissue implants in the SCID mouse model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930500124106

Anti-interleukin 6 receptor antibody treatment in rheumatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930500124106

Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930500124106

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930500124106

Soluble interleukin-6 receptors in inflammatory bowel disease: relation to circulating interleukin-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930500124106

Blockade of interleukin 6 trans signaling suppresses T-cell resistanceagainst apoptosis in chronic intestinal inflammation: Evidence in Crohn diseaseand experimental colitis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930500124106

CIS3/SOCS3/SSI3 plays a negative regulatory role in STAT3 activation and intestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930500124106

Macrophage-derived IL-18-mediated intestinal inflammation in the murine model of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930500124106

A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930500124106

Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930500124106

Interleukin 6 as a therapeutic target in systemic-onset juvenile idiopathic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930500124106

10.1080/08916930500124106

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference

PubMed ID

16227151